On October 2, 2026, the clinical trial registry listed an update for a study involving substance p. The trial, titled "PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R61 Phase Pilot)," is registered as NCT07218562. The study is designated as Phase 2. Its current status is listed as completed as of this update date.
Substance p remains classified as unapproved for research use, with no approved therapeutic indication. This update reflects only the trial's registered status change and does not include any reported outcomes or results. No efficacy, safety, or benefit information has been disclosed in connection with this status update.
Readers should note that a completed status indicates the trial has concluded its defined phase of activity, not that findings have been published or reviewed. Further details, if released, would typically appear as a separate publication or results posting on the registry. For additional context on substance p, including its research background, readers can consult the compound overview.